All Articles

• Epidemic of E. coli infections traced to one strain

  Virulent, drug-resistant forms of Escherichia coli that have recently spread around the world emerged from a single strain of the bacteria—not many different strains, as has been widely supposed, according to a new study in mBio, the flagship journal of the American Society for Microbiology. The strain causes millions of urinary, kidney, and bloodstream infections a year and has a far greater clinical and economic impact than any other strain of bacteria, including the so-called MRSA (methicillin-resistant Staphylococcus aureus) superbug.”
• 3 decades on: How Group Health’s practical research changed health care

  When we say that Group Health Research Institute (GHRI) does practical research to help people like you and your family stay healthy, what do we mean? The short answer: We study what works—and what doesn't—to achieve the most important outcome for people.
• GHRI’s next 30 years: Imagine personalized medicine, empowered patients, better health

  For Group Health Research Institute’s (GHRI) 30th anniversary, we asked our faculty and staff: How will your work today influence health and health care 30 years from now, in the year 2043?
• Allen Foundation drives traumatic brain injury study forward

  The Paul G. Allen Family Foundation has awarded a new $2.37-million grant to help Seattle-area researchers embark on an important research effort designed to investigate the lasting effects of traumatic brain injuries—an area that has long been filled with question marks for physicians and scientists.
• High-risk women get breast MRI—but room remains for improvement

  A large national study in JAMA Internal Medicine has found that the rate of women receiving breast MRI (magnetic resonance imaging) nearly tripled from 2005 to 2009: from four to 11 exams per 1,000 women.
• Group Health and UW scientist Bruce M. Psaty, MD, PhD, named to Institute of Medicine

  The Institute of Medicine (IOM) announced today, Oct. 21, that Bruce M. Psaty, MD, PhD, has been newly elected into its membership ranks, one of the most prestigious honors in the fields health and medicine.
• Less blood clot risk is linked to estradiol than to Premarin pills

  In an observational study of comparative safety, use of estradiol was associated with less risk of developing blood clots in leg veins (deep vein thrombosis) and clots in the lungs (pulmonary emboli) than was use of conjugated equine estrogens.